Every week in my dermatology practice, I see women in their late 30s and 40s who describe the same constellation of changes: fatigue that coffee can't fix, sleep that doesn't restore, weight that won't respond to diet, and skin that has lost its resilience. They've been told this is aging. I tell them it's a mechanism — and mechanisms are addressable.
The distinction matters. "Aging" implies inevitability. A mechanism implies a process with inputs, outputs, and potential interventions. When you understand what is actually declining — and when — the conversation shifts from resignation to strategy.
What declines — and when
The three hormones most relevant to how women feel and function — estrogen, progesterone, and testosterone — begin declining in the mid-to-late 30s. This is not menopause. This is perimenopause, a transitional phase that can last a decade or more before periods stop entirely. During this window, hormone levels fluctuate unpredictably, creating symptoms that are often dismissed as stress, poor sleep hygiene, or simply getting older.
Progesterone is typically the first to decline, often beginning in the early-to-mid 30s. This affects sleep quality, anxiety levels, and mood stability. Estrogen follows, declining more steeply in the 40s. Testosterone — which women produce in smaller quantities than men but rely on for energy, libido, and muscle maintenance — declines gradually throughout this period. The cumulative effect is a cascade: each declining hormone amplifies the impact of the others.
The symptoms most people accept as 'just aging'
Sleep disruption. Brain fog. Unexplained weight gain, particularly around the midsection. Low libido. Mood changes that feel disproportionate to circumstance. Fatigue that persists regardless of how much rest you get. Joint stiffness. Hair changes. These are not separate, unrelated problems. They are downstream effects of the same hormonal decline — different expressions of a single underlying mechanism.
What I find most concerning is how frequently these symptoms are normalized. Women are told they need more sleep, less stress, a better diet, or a new exercise routine. These are not bad suggestions. But they do not address the root cause. You cannot out-exercise a progesterone deficiency. You cannot meditate your way to adequate estrogen levels.
The skin connection — what your dermatologist sees
As a dermatologist, I have a unique window into hormonal decline because I see its effects on the largest organ in the body. Estrogen is directly involved in collagen production, skin hydration, and barrier function. When estrogen declines, collagen production drops with it — studies suggest women can lose up to 30 percent of their skin collagen in the first five years of perimenopause. That is not a gradual fade. That is a significant structural change happening in a compressed timeframe.
Barrier dysfunction follows. The skin becomes drier, more reactive, slower to heal. Elasticity declines. Fine lines deepen. These changes are often what bring patients to my practice in the first place — they notice their skin is changing rapidly and want to understand why. When I see a patient whose skin is aging faster than expected, I am seeing a biological signal. The same estrogen that maintains skin structure also drives energy, cognitive clarity, and metabolic function. The skin is telling us something about the whole system.
Ready to address the mechanism?
Join the Waitlist →Why 75% of women seeking menopause care receive none
Despite the prevalence of perimenopausal and menopausal symptoms, the majority of women who seek medical help are undertreated or untreated. The numbers are striking: an estimated 75 percent of women who present to a healthcare provider with menopause-related complaints leave without receiving hormone therapy. The reasons are systemic. Most medical schools dedicate minimal curriculum hours to menopause. Many primary care providers lack training in hormone replacement. And a generation of physicians was taught to fear HRT based on a misinterpretation of the 2002 Women's Health Initiative study.
That study — which used synthetic, non-bioidentical hormones in an older patient population — created a chilling effect on HRT prescribing that persists to this day. Subsequent re-analysis and newer research have demonstrated that hormone therapy initiated in the perimenopausal window, using bioidentical formulations, carries a meaningfully different risk profile. But the damage to clinical practice was done. An entire generation of women was told that hormone replacement was dangerous. Many of their physicians still believe it.
What bioidentical HRT actually does
Bioidentical hormone replacement therapy restores what your body has stopped producing in adequate quantities. The term "bioidentical" means the molecular structure of the administered hormones is identical to what your own body produces. These are not synthetic analogs with altered chemical structures. They are the same molecules — estradiol, progesterone, testosterone — delivered in personalized doses based on your individual biology, lab values, and symptom profile.
The goal is not to return you to the hormone levels of a 25-year-old. The goal is to restore physiological levels that allow your body to function as it is designed to — sleeping deeply, maintaining bone density, preserving cognitive sharpness, supporting skin structure, and sustaining the energy required to live your actual life. Dosing is individualized. Monitoring is ongoing. This is not a one-size-fits-all prescription. It is personalized medicine in the truest sense.
The mechanism is clear. The intervention exists. The question is whether you have access to a physician who understands it and a protocol designed around your biology — not an average.